Home/Filings/4/0001162157-25-000005
4//SEC Filing

RAPPAPORT ANDREW 4

Accession 0001162157-25-000005

CIK 0001750284other

Filed

Nov 24, 7:00 PM ET

Accepted

Nov 25, 6:00 PM ET

Size

9.3 KB

Accession

0001162157-25-000005

Insider Transaction Report

Form 4
Period: 2025-11-21
Transactions
  • Exercise/Conversion

    Common Stock

    2025-11-21$0.39/sh+35,868$13,98935,868 total
  • Gift

    Common Stock

    2025-11-2535,8680 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-11-2135,8680 total
    Exercise: $0.39Exp: 2025-12-20Common Stock (35,868 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    385,965
Footnotes (3)
  • [F1]The reporting person transferred 35,868 to the Rappaport Family Foundation, a charitable foundation of which the reporting person is an officer, as a bona fide gift for no consideration. The reporting person has voting and dispositive power over all securities owned by the foundation.
  • [F2]The shares are held by the Rappaport Family Trust, of which the reporting person is co-trustee.
  • [F3]The shares subject to the option are fully vested.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001162157

Filing Metadata

Form type
4
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 6:00 PM ET
Size
9.3 KB